| Product NDC: | 51672-2097 |
| Proprietary Name: | Cetirizine Hydrochloride |
| Non Proprietary Name: | Cetirizine Hydrochloride |
| Active Ingredient(s): | 10 mg/1 & nbsp; Cetirizine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-2097 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA078072 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090722 |
| Package NDC: | 51672-2097-1 |
| Package Description: | 1 BOTTLE in 1 CARTON (51672-2097-1) > 100 TABLET in 1 BOTTLE |
| NDC Code | 51672-2097-1 |
| Proprietary Name | Cetirizine Hydrochloride |
| Package Description | 1 BOTTLE in 1 CARTON (51672-2097-1) > 100 TABLET in 1 BOTTLE |
| Product NDC | 51672-2097 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Cetirizine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090722 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | CETIRIZINE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |